skip navigationU S P T O SealUnited States Patent and Trademark Office TTABVUE logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
TTABVUE. Trademark Trial and Appeal Board Inquiry System
v2.5.0

Opposition

Number:91283601Filing Date:02/22/2023
Status:TerminatedStatus Date:07/10/2024
General Contact Number:571-272-8500
Interlocutory Attorney:CHARLES HISER
Paralegal Name:CHAUNTE T AUSTIN
Defendant
Name:Vydiant, Inc.
Correspondence:JONATHAN O OWENS
HAVERSTOCK & OWENS LLP
162 NORTH WOLFE ROAD
SUNNYVALE, CA 94086
UNITED STATES
jowens@hollp.com
Phone: 408-530-9700
 
Serial #:97169997Application FileAssignment
Application Status: NOTICE OF ALLOWANCE - ISSUED
Mark: 1HEALTH
Plaintiff
Name:1HealthSciences, Inc.
Correspondence:EMILY ROHM BILLIG
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ PC
100 LIGHT STREET 19TH FLOOR
BALTIMORE, MD 21202
UNITED STATES
ebillig@bakerdonelson.com, trademarks@bakerdonelson.com, mtorres@bakerdonelson.com
Phone: 410-862-1089
 
Serial #:97602149Application FileAssignment
Application Status: ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
Mark: 1HEALTH
Prosecution History
#DateHistory TextDue Date
2107/10/2024TERMINATED
2007/10/2024BD DECISION: OPP DISMISSED W/ PREJ
1905/07/2024SUSP PEND DISP OF OUTSTNDNG MOT
1805/07/2024D MOT FOR SUMMARY JUDGMENT
1705/06/2024TRIAL DATES RESET
1605/02/2024D MOT FOR SUMMARY JUDGMENT
1508/22/2023TRIAL DATES RESET
1407/05/2023D REPLY IN SUPPORT OF MOTION
1306/15/2023P OPP/RESP TO MOTION
1206/01/2023SUSP PEND DISP OF OUTSTNDNG MOT
1105/26/2023D MOT TO DISMISS: FRCP 12(B)
1005/26/2023ANSWER
904/28/2023BD ORDER: CONSOLIDATED (PARENT); TRIAL DATES RESET
804/20/2023P MOT TO AMEND PLEADING/AMENDED PLEADING
704/18/2023D MOT TO DISMISS: FRCP 12(B) (REVISED)
604/17/2023SUSP PEND DISP OF OUTSTNDNG MOT
503/31/2023ANSWER
403/31/2023D MOT TO DISMISS: FRCP 12(B)
302/22/2023INSTITUTED
202/22/2023NOTICE AND TRIAL DATES SENT; ANSWER DUE:04/03/2023
102/22/2023FILED AND FEE
Results as of 11/21/2024 03:52 PM
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY POLICY